These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33162185)

  • 1. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
    Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
    Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered microRNA expression profile is linked to T-cell exhaustion-related pathways in pediatric patients with acute lymphoblastic leukemia.
    Zidan M; Zidan AA; Attia Saad M; El-Shanshory M; Bakry U; Sobh A; Mohammed Abdou S; Labib Salem M
    Hum Immunol; 2023 Feb; 84(2):113-122. PubMed ID: 36347735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy alters the increased numbers of myeloid-derived suppressor and regulatory T cells in children with acute lymphoblastic leukemia.
    Salem ML; El-Shanshory MR; Abdou SH; Attia MS; Sobhy SM; Zidan MF; Zidan AA
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):158-167. PubMed ID: 29388481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.
    Zahran AM; Shibl A; Rayan A; Mohamed MAEH; Osman AMM; Saad K; Mahmoud KH; Ghandour AMA; Elsayh KI; El-Badawy O
    Sci Rep; 2021 Jul; 11(1):15039. PubMed ID: 34294814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of CD4
    El-Maadawy EA; Elshal MF; Bakry RM; Moussa MM; El-Naby S; Talaat RM
    Mol Immunol; 2020 Aug; 124():1-8. PubMed ID: 32480291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
    Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
    Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
    Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
    Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.
    Wang R; Feng W; Wang H; Wang L; Yang X; Yang F; Zhang Y; Liu X; Zhang D; Ren Q; Feng X; Zheng G
    Cancer Lett; 2020 Jan; 469():151-161. PubMed ID: 31669202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.
    Ren JP; Wang L; Zhao J; Wang L; Ning SB; El Gazzar M; Moorman JP; Yao ZQ
    Immunology; 2017 Feb; 150(2):213-220. PubMed ID: 27753084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma.
    Siret C; Collignon A; Silvy F; Robert S; Cheyrol T; André P; Rigot V; Iovanna J; van de Pavert S; Lombardo D; Mas E; Martirosyan A
    Front Immunol; 2019; 10():3070. PubMed ID: 32038621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
    Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
    Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial.
    Jiménez-Cortegana C; Palazón-Carrión N; Martin Garcia-Sancho A; Nogales-Fernandez E; Carnicero-González F; Ríos-Herranz E; de la Cruz-Vicente F; Rodríguez-García G; Fernández-Álvarez R; Rueda Dominguez A; Casanova-Espinosa M; Martínez-Banaclocha N; Gumà-Padrò J; Gómez-Codina J; Labrador J; Salar-Silvestre A; Rodriguez-Abreu D; Galvez-Carvajal L; Provencio M; Sánchez-Beato M; Guirado-Risueño M; Espejo-García P; Lejeune M; Álvaro T; Sánchez-Margalet V; de la Cruz-Merino L; ; ;
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34158317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway.
    Pang B; Zhen Y; Hu C; Ma Z; Lin S; Yi H
    Clin Sci (Lond); 2020 Aug; 134(16):2209-2222. PubMed ID: 32808653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of microRNAs on myeloid-derived suppressor cells in cancer.
    Baghbani E; Noorolyai S; Duijf PHG; Silvestris N; Kolahian S; Hashemzadeh S; Baghbanzadeh Kojabad A; FallahVazirabad A; Baradaran B
    Hum Immunol; 2021 Sep; 82(9):668-678. PubMed ID: 34020831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting myeloid-derived suppressive cells in the tumor microenvironment to enhance the efficacy of cancer immunotherapy.
    Huo S; Liu L; Li Q; Wang J
    Discov Med; 2020; 30(161):119-128. PubMed ID: 33593480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia.
    Del Gaizo M; Sergio I; Lazzari S; Cialfi S; Pelullo M; Screpanti I; Felli MP
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.